(Q80706448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

Ryuji Kubota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Masako Ohno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Tomoko Hasunuma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Hajime Iijima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Junichi Azuma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

31 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

927-933

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17665185%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-007-0333-1

2 January 2020

exact match

0 references

cites work

Therapeutic drug monitoring in the treatment of tuberculosis

1 reference

12 December 2020

Expression of arylamine N-acetyltransferase in human intestine

1 reference

12 December 2020

Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity

1 reference

12 December 2020

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine

1 reference

12 December 2020

DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity

1 reference

12 December 2020

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

12 December 2020

Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population

1 reference

12 December 2020

Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients

1 reference

12 December 2020

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide

1 reference

12 December 2020

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

1 reference

12 December 2020

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

1 reference

12 December 2020

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?

1 reference

12 December 2020

Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.

1 reference

12 December 2020

Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver

1 reference

12 December 2020

The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid

1 reference

12 December 2020

Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis

1 reference

12 December 2020

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity

1 reference

12 December 2020

Pharmacogenetics of the arylamine N-acetyltransferases.

1 reference

12 December 2020